Stephen Hardt

Stephen Hardt is the Senior Vice President of Supply Chain and External Manufacturing for Allogene, overseeing the planning, sourcing, manufacturing, logistics, and distribution of the AlloCar T™ cell products. Stephen has extensive experience in technical operations, supply chain strategy, manufacturing, and portfolio management. Prior to joining Allogene, he worked for Genentech for 15 years where he held various senior leadership roles, most recently as the Vice President of Technical Product Management and Network Strategy. In this role, Stephen developed and executed product strategies for a portfolio of over 40 products and led the biologic and small molecule CMC team system, and his team oversaw numerous global product launches including Tecentriq®, Ocrevus®, and Hemlibra®. At Genentech, Stephen was also the Global Head of Contract Manufacturing Operations, providing leadership for a broad external network of drug substances, drug products, and clinical manufacturing sites. Prior to joining Genentech, he held various leadership roles across the biotech and diagnostic industries. Stephen holds a B.S. Degree in Biology from the University of California, San Diego.